Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI)
PHARMACEUTICAL PREPARATIONS
Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) is listed on Nasdaq, where it has traded since November 20, 2020.
- Listed On
- Nasdaq
- Listed Since
- November 20, 2020
- Employees
- 415
- Market Cap
- $1.3B
About Maravai LifeSciences Holdings, Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 174 institutions reported holding MRVI, with 140.2 million shares worth $874.6 million in aggregate. The largest reported holder was Gtcr, with 20.2 million shares worth $125.7 million. Of the 5 largest holders listed below, 2 added shares, 2 reduced their positions and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Gtcr | 20,150,005 | $126M | Unchanged |
| BlackRock | 9,970,780 | $62M | Added 6.69% |
| Braidwell | 8,702,921 | $54M | Reduced 15.01% |
| Vanguard | 7,263,964 | $45M | Added 0.49% |
| 12 West Capital Management | 7,060,195 | $44M | Reduced 2.75% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is MRVI?
Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) is listed on Nasdaq, where it has traded since November 20, 2020.
Who are the largest institutional holders of MRVI?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of MRVI were Gtcr, BlackRock and Braidwell.
How many institutions own MRVI?
174 institutions reported a position in MRVI for the quarter ended June 30, 2026, worth $874.6 million in total.
Did institutions buy or sell MRVI last quarter?
Of the 5 largest reported holders, 2 added shares, 2 reduced their positions and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for MRVI.
Every reported institutional holder, plus insider and congressional trades in MRVI, on SentiSense.